Resultado da Busca
Há 5 dias · On a special episode of The BioCentury Show, Narasimhan describes where he envisions Scemblix asciminib, an allosteric BCR-ABL binder, fitting into the treatment paradigm for newly diagnosed chronic myelogenous leukemia (CML) patients.
23 de mai. de 2024 · The appointment was part of the strategy of Novartis CEO Vasant Narasimhan, who declared at the time that he didn't want to bring the largest number of drugs to the market, but the most...
Há 5 dias · Vasant (Vas) Narasimhan Shreeram Aradhye Victor Bulto Aharon (Ronny) Gal Karen L. Hale Patrick Horber Harry Kirsch Rob Kowalski Steffen Lang Fiona Marshall Klaus Moosmayer Lutz Hegemann Kees Roks Michelle Weese
Há 4 dias · Vasant Narasimhan is 44, he's been the Chief Executive Officer and Member of the Executive Committee of Novartis AG since 2018. There are 41 older and no younger executives at Novartis AG. The oldest executive at Novartis AG is Alex Krauer, 70, who is the Honorary Chairman of the Board.
Há 6 dias · Global pharma saw three big mergers in 2009, driven by the high cost of drug development. Fifteen years later, the strategy is to hive off allied businesses to focus on pure-play innovative ...
17 de mai. de 2024 · High-profile company executives like Novartis’ CEO Vasant Narasimhan have praised unbossing and built a culture around it, lending some credence to the idea that the method can solve current productivity challenges by making employees feel a stronger sense of ownership and connection to their work and organizations in hybrid ...
24 de mai. de 2024 · The decision is the latest big strategic move by new Chief Executive Vasant Narasimhan, MD, who has pledged to refocus Novartis on drug development after taking over the CEO role earlier this year. In 2011, Novartis completed its purchase of Alcon, which was acquired in stages from Nestlé in a deal more than $50 billion.
